Press Releases

Debiopharm Investment strengthens its presence in the renewable energy sector

GenePOC to Announce CE Marking of its revogene™ Instrument and its Second Test, CDiff

Debiopharm International SA Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients

Debiopharm Group’s Triptorelin 6-month Formulation Receives Approval for the Treatment of Central Precocious Puberty (CPP) in Europe

Les projets «Hello Mask» et «Le 5ème mur» remportent le Challenge Debiopharm-Inartis 2016 sur la Qualité de Vie des Patients

GenePOC announces setup of an extensive network of commercial partners across Europe for Distribution

Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450

Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy

Coorpacademy raises 10 million euros and achieves one of the most important fundraisings in the European EdTech sector